Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 2
Submit an article Journal homepage
801
Views
0
CrossRef citations to date
0
Altmetric
Clinical / Regulatory

Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal

Ram Hari Chapagaina OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, Nepal;b Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, NepalORCID Iconhttps://orcid.org/0000-0001-5939-5471View further author information
ORCID Icon,
Jessica Maharjana OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Santosh Adhikaria OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalORCID Iconhttps://orcid.org/0000-0003-4345-6131View further author information
ORCID Icon,
Prabhat Thapaa OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Kshitij Kunwara OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Bishnu Rath Giria OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Nisha Jyoti Shresthaa OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, Nepal;b Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, NepalView further author information
,
Anil Kumar Shresthaa OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, Nepal;b Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, NepalView further author information
,
Sanjeet Kumar Shresthaa OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Suresh Man Tamanga OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Haeun Choc Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Eun Lyeong Parkc Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Jiyoung Leec Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Jinae Leec Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Deok Ryun Kimc Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Jae Seung Yangd Science Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Tarun Salujae Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Anh Wartelf Europe Regional Office Director, International Vaccine Institute (IVI), Seoul, KoreaView further author information
,
Julia Lynchg Cholera Program Director, International Vaccine Institute (IVI), Seoul, KoreaView further author information
&
Katerina Rok Songe Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute (IVI), Seoul, KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4613-6240View further author information
ORCID Icon show all
Article: 2239680 | Received 25 Apr 2023, Accepted 19 Jul 2023, Published online: 04 Aug 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.